(Press-News.org) Contact information: Jennifer Vogel
jennifer.vogel@ctca-hope.com
623-207-3241
Cancer Treatment Centers of America
CTCA doctor featured expert speaker at Society for Immunotherapy of Cancer
Dr. Walter Quan presenting cutting-edge treatments for cancer patients to medical colleagues
GOODYEAR, AZ – November 8th, 2013 – Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America® (CTCA) Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.
The Society for Immunotherapy of Cancer (SITC) national meeting is being held in National Harbor, MD November 7-10, 2013. Hundreds of expert doctors from all over the country will attend workshops, learn new techniques and engage in a hot topic symposium.
Dr. Quan will be speaking on two topics, the first is a new treatment that involves a combination chemoimmunotherapy with monthly cycles of 5-Fluorouracil + Interferon-alfa-2b in previously-treated advanced cancer (with CTCA co-authors Dr. Vivek Khemka, Dr. Laura Martel, and Marci Pierog RN). Combination chemoimmunotherapy is a study in which we treated 18 patients who all had had their advanced cancers grow despite at least 2 different types of chemotherapy treatments. The rationale for our chemoimmunotherapy combination (given over 3 days per month) was to use a chemotherapy drug called 5-Fluorouracil to essentially "soften up" the person's cancer to an attack from that patient's immune system which was stimulated by the immune system booster Interferon-alfa-2b. The treatment was well-tolerated with flu-like symptoms such as fever, shivers, and nausea being the most common side effects. One patient with widely spread non-small cell lung cancer has had shrinkage of her cancer, ongoing at over 1 year. Another patient with colon cancer spread to liver and lymph nodes has had shrinkage of his cancer, ongoing at more than 4 months.
The second topic discusses an activity of dose-dense outpatient intravenous Interleukin-2 preceded by famotidine in metastatic clear cell cancer of the kidney (which is based on work done at Loma Linda). This is a study in which the messenger attack protein Interleukin-2 (the immune system's "911" call) was used along with the antihistamine famotidine (which acts like a signal enhancer) to treat people with widely spread kidney cancer as an outpatient. The rationale for this treatment (which was given for 3 days per week for 6 consecutive weeks) is to send wave after wave of super-charged cancer-killing white blood cells to attack a person's kidney cancer. Five of fifteen patients treated on this study have had their cancer shrink by at least 50% and one patient had his cancer disappear completely from his lungs.
###
For more information on SITC visit http://www.sitcancer.org/2013/annual-meeting
About Cancer Treatment Centers of America
CTCA is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with information about cancer and their treatment options so they can control their treatment decisions. For more information about CTCA, go to http://www.cancercenter.com. END
CTCA doctor featured expert speaker at Society for Immunotherapy of Cancer
Dr. Walter Quan presenting cutting-edge treatments for cancer patients to medical colleagues
2013-11-08
ELSE PRESS RELEASES FROM THIS DATE:
Slacktivism: 'Liking' on Facebook may mean less giving
2013-11-08
Slacktivism: 'Liking' on Facebook may mean less giving
Would-be donors skip giving when offered the chance to show public support for charities in social media, a new study from the University of British Columbia's Sauder School of Business finds.
"Charities ...
Tracking young salmon's first moves in the ocean
2013-11-08
Tracking young salmon's first moves in the ocean
Knowledge informs efforts to restore endangered salmon stocks
RICHLAND, Wash. – Basic ocean conditions such as current directions and water temperature play a huge role in determining the behavior of ...
Dartmouth researchers shed new light on dark energy, cosmic speed-up
2013-11-07
Dartmouth researchers shed new light on dark energy, cosmic speed-up
Study uses Big Bang afterglow to show Earth has no special place in expanding universe
In a new study, Dartmouth researchers rule out a controversial theory that the accelerating expansion of the ...
OU natural products discovery group asks for public's help with citizen science program
2013-11-07
OU natural products discovery group asks for public's help with citizen science program
Crowdsourcing engages the public in the scientific process and enhances drug discovery
The University of Oklahoma Natural Products Discovery Group has taken an unconventional approach ...
Study shows that parenting improves with coaching via cell phone
2013-11-07
Study shows that parenting improves with coaching via cell phone
n the first randomized trial of the effects of cell phone use, University of Kansas and Notre Dame researchers found that when parenting coaches texted and called mothers who had participated in a ...
MU researchers determine televised presidential debates help moderates choose candidates
2013-11-07
MU researchers determine televised presidential debates help moderates choose candidates
COLUMBIA, Mo. – Televised presidential debates have been a staple of the political landscape for more than 50 years. Starting in 1960 with John F. Kennedy and Richard ...
Saddling up against the threat to our National Parks
2013-11-07
Saddling up against the threat to our National Parks
The growing threat to our National Parks from horse dung
Research team leader, Associate Professor Catherine Pickering, said the Griffith study looked at the number and types of weed seeds which can be dispersed ...
BPA in dialysis machine components may be toxic to patients' cells
2013-11-07
BPA in dialysis machine components may be toxic to patients' cells
Atlanta, GA (November 7, 2013)—Levels of bisphenol A (BPA) in components of dialysis machines may be toxic to the immune cells circulating in kidney failure patients' blood, according ...
Consuming more vegetable protein may help kidney disease patients live longer
2013-11-07
Consuming more vegetable protein may help kidney disease patients live longer
Atlanta, GA (November 7, 2013)—Increased consumption of vegetable protein was linked with prolonged survival among kidney disease patients in a new a study. The findings will ...
Fountain-of-youth gene repairs tissue damage in adults
2013-11-07
Fountain-of-youth gene repairs tissue damage in adults
Young animals recover from tissue damage better than adults, and from Charles Darwin's time until now, scientists have puzzled over why this is the case. A study published by Cell Press November 7th in the journal Cell ...
LAST 30 PRESS RELEASES:
Father’s mental health can impact children for years
Scientists can tell healthy and cancerous cells apart by how they move
Male athletes need higher BMI to define overweight or obesity
How thoughts influence what the eyes see
Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect
Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation
Could opioid laws help curb domestic violence? New USF research says yes
NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow
Scientists identify agent of transformation in protein blobs that morph from liquid to solid
Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss
Research identifies key enzyme target to fight deadly brain cancers
New study unveils volcanic history and clues to ancient life on Mars
Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome
Scientists probe the mystery of Titan’s missing deltas
Q&A: What makes an ‘accidental dictator’ in the workplace?
Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture
Study highlights gaps in firearm suicide prevention among women
People with medical debt five times more likely to not receive mental health care treatment
Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B
Rise in claim denial rates for cancer-related advanced genetic testing
Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use
Medical debt and forgone mental health care due to cost among adults
Colder temperatures increase gastroenteritis risk in Rohingya refugee camps
Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine
Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury
AERA announces winners of the 2025 Palmer O. Johnson Memorial Award
Mapping minds: The neural fingerprint of team flow dynamics
Patients support AI as radiologist backup in screening mammography
AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy
Existing drug has potential for immune paralysis
[Press-News.org] CTCA doctor featured expert speaker at Society for Immunotherapy of CancerDr. Walter Quan presenting cutting-edge treatments for cancer patients to medical colleagues